盟科药业 (688373)

Shanghai MicuRx Pharmaceutical Co., Ltd.

KSH

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 65560.55
  • Circulating A-Shares(W): 52549.15
  • Earnings Per Share(RMB): -0.3000
  • Net Assets Per Share(RMB): 0.3928
  • Operating Revenue(W RMB): 10398.53
  • Total Profit(W RMB): -19340.72
  • **Net Profit Attributable to Parent(W RMB) **: -19353.61
  • Net Profit Growth Rate(%): 33.56
  • Weighted Return on Equity(%): -55.5700
  • Operating Cash Flow Per Share(RMB): -0.2530
  • Undistributed Profit Per Share(RMB): -3.0479
  • Capital Reserve Per Share(RMB): 2.4225

2. Main Business

The main business covers:

  • Discovery, development, and commercialization of innovative drugs targeting unmet clinical needs.

3. Company Basic Information

  • Company Name: Shanghai MicuRx Pharmaceutical Co., Ltd.
  • Listing Date: 2022-08-05
  • Industry: Pharmaceutical Manufacturing
  • Address: Building 1, 1-4/F, 101, No. 53 Edison Road, China (Shanghai) Pilot Free Trade Zone, and Building 2
  • Website: https://www.micurxchina.com/
  • Company Profile: The company is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative drugs, committed to addressing unmet clinical needs. The company completed its joint-stock reform in 2020 and was listed on the STAR Market in 2022.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Best Idea International Limited Corporate Entity 5843.90 11.12
2 JSR Limited Corporate Entity 3084.45 5.87
3 MicuRx(HK)Limited Corporate Entity 2612.71 4.97
4 GP TMT Holdings Limited Corporate Entity 1837.13 3.50
5 Huagai Capital Co., Ltd. - Beijing Huagai Xincheng Yuanhang Medical Industry Investment Partnership (Limited Partnership) Corporate Entity 1288.38 2.45
6 Xinyi Youmaikesi Financial Consulting Center (Limited Partnership) Corporate Entity 713.07 1.36
7 GF Securities Co., Ltd. Securities Firm 691.45 1.32
8 Beijing Tidesun Private Fund Management Co., Ltd. - Tidesun Investment Zhisheng Quantitative 1 Private Securities Investment Fund Private Securities Investment Fund 650.71 1.24
9 Minsheng Jianyin Pension Services Flexible Allocation Mixed Securities Investment Fund Fund 2.26 0.00

5. Concept Sectors

  • Innovative Drugs
  • Margin Trading & Securities Lending
  • High Price-to-Book Ratio
  • Loss-Making Stocks
  • Heavily Held by Securities Firms
  • Private Placement Plan
  • Consecutive Losses
  • Below IPO Price
  • Planned Reduction
  • STAR Market Growth Layer

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information